Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice Models

22 Feb 2022

Abstract excerpt

Coronavirus disease 2019 (COVID-19) has caused massive health and economic disasters worldwide. Although several vaccines have effectively slowed the spread of the virus, their long-term protection and effectiveness against viral variants are still uncertain. To address these potential shortcomings, this study proposes a peptide-based vaccine to prevent COVID-19. A total of 15 B cell epitopes of the wild-type...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35336856
DOI: 10.3390/v14030449

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice ModelsPMID 35336856Read ↗

Prophylactic domain-based vaccine against SARS-CoV-2, causative agent of COVID-19 pandemicSemantic proximity Read ↗

Design of Peptide Vaccine for COVID19: CD8+ and CD4+ T cell epitopes from SARS-CoV-2 open-reading-frame protein variantsSemantic proximity Read ↗

Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.Semantic proximity Read ↗

Multi-Epitope Vaccine Design Using an Immunoinformatic Approach for SARS-CoV-2Semantic proximity Read ↗

In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate VaccineSemantic proximity Read ↗

Essential Considerations During Vaccine Design against COVID-19 and Review of Pioneering Vaccine Candidate PlatformsSemantic proximity Read ↗

Immunoinformatics design of B and T-cell epitope-based SARS-CoV-2 peptide vaccinationSemantic proximity Read ↗

An Overview of Vaccine Development for COVID-19Semantic proximity Read ↗

Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and ValidationSemantic proximity Read ↗

COVID-19 Vaccines: Where Do We Stand at the End of 2023?Semantic proximity Read ↗

Designing a multi-epitope peptide based vaccine against SARS-CoV-2Semantic proximity Read ↗

Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.